Core Insights - Hainan has introduced measures to support the high-end medical device and digital therapy industries, focusing on "high-end innovation" and "digital integration" to create a comprehensive support system covering research, registration, production, and application [2][3] Group 1: Industry Development - The biopharmaceutical industry is a key focus for Hainan's free trade port, with rapid growth driven by policy advantages [2] - The number of registered medical device companies in Hainan has increased from 64 in 2021 to 144 currently, while the total number of product registrations has risen from 146 to 548 [2] - The product structure is evolving from low-value consumables to high-value areas such as orthopedic implants, active devices, digital therapies, and AI software [2] Group 2: Policy Measures - The measures include support for high-end medical device innovation through real-world data application, establishment of high-level R&D platforms, and encouragement of collaboration among industry, academia, and healthcare [3] - For digital therapy, the measures propose a "green channel" for product registration, enhanced R&D guidance, and a mechanism for ongoing government-business communication [3] Group 3: Competitive Advantage - The implementation of these policies is expected to enhance Hainan's competitiveness in the medical device sector, positioning it as a hub for high-end medical device innovation and a global center for digital therapy [4]